Comparison of Ketamine and Morphine in patients with renal colic

Evaluation the therapeutic effects of intravenous Ketamine and intravenous Morphine in the treatment of patients with renal colic

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

IRCT

Registry ID

IRCT20180530039917N2

Enrollment

136

Registered

2019-03-05

Start date

2018-04-09

Completion date

Unknown

Last updated

2019-03-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Renal Colic. Unspecified renal colic

Interventions

Intervention 1: Intervention group: A single dose of 0.3 mg/kg Intravenous Ketamine. Intervention 2: Intervention group: A single dose of 0.1 mg/kg Intravenous Morphine.

Eligibility

Sex/Gender

All

Age

18 Years to 65 Years

Inclusion criteria

Inclusion criteria: VAS more than 5 Patients with renal colic due to stones (confirmed by imaging)

Exclusion criteria

Exclusion criteria: History of cardiovascular disease and hypertension Pregnancy Breastfeeding Drug addiction History of seizure Glaucoma

Design outcomes

Primary

Measure	Time frame
Pain level. Timepoint: Before the intervention, 5, 10, 20, 30 and 60 minutes after the intervention. Method of measurement: Visual analogue scale.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactReza Naji

Ahvaz University of Medical Sciences

srnaji@gmail.com+98 21 8670 5503

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026